The Valley Desk

Clinical trial reportJournal of neuro-oncologyPublished

Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of neuro-oncology
Published
Subject terms
Humans; Glioblastoma; Brain Neoplasms; Neoplasm Recurrence, Local; Sulfones; Indans; Vascular Endothelial Growth Factor A; Adult; Aged; Middle Aged; Hypoxia; hypoxia-inducible factor
PubMed ID
37864646
PubMed Central ID
PMC10863646
Added to directory
Source checked

Report a correction or request removal